Immunohistochemical detection of retinoic acid receptor-α in prostate carcinoma: Correlation with proliferative activity and tumor grade

被引：17

作者：

Gyftopoulos K. ^{[1
]}

Perimenis P. ^{[1
]}

Sotiropoulou-Bonikou G. ^{[2
]}

Sakellaropoulos G. ^{[3
]}

Varakis I. ^{[2
]}

Barbalias G.A. ^{[1
]}

机构：

[1] Departments of Urology, School of Medicine, University of Patras, Patras

[2] Departments of Anatomy, School of Medicine, University of Patras, Patras

[3] Departments of Medical Physics, School of Medicine, University of Patras, Patras

来源：

International Urology and Nephrology | 2000年 / 32卷 / 2期

关键词：

Immunohistochemistry; Ki67; Prostate carcinoma; Retinoic acid receptor-α;

D O I：

10.1023/A:1007126332651

中图分类号：

学科分类号：

摘要：

Background: The use of retinoids as differentiation therapy is a novel approach to prostate cancer. Retinoids act via their own nuclear receptors, RARs and RXRs, modulating gene activity, cell growth and differentiation. This study provides new data on the content and cellular distribution of RARα protein in prostate cancer specimens, in correlation to tumor grade and proliferative activity. Material and methods: A total of 84 cases of primary prostate carcinoma, divided into 3 subgroups according to tumor grade, were immunohistochemically evaluated for retinoic acid receptor-α (RARα) and Ki67 using the streptavidin/peroxidase method on formalin fixed, paraffin embedded tissues. Results: RARα positivity was detected in all cases of prostatic carcinoma, with a more profound expression in well differentiated cancers. A statistically significant correlation between RARα staining and tumor grade was found (ANOVA, p < 0.031). Ki67 immunoreactivity was present in 35.7% of cases, but no correlation with tumor grade was found. When RARα staining was correlated with Ki67 positivity, a statistically significant correlation was present (unpaired t-test, p < 0.003). Conclusions: These findings indicate that RARα expression is correlated to some extent with tumor grade and its presence is more profound in highly proliferative tumors. Further studies are needed to establish the possible clinical value of the immunohistochemical evaluation of RARα content in tumor specimens.

引用

页码：263 / 269

页数：6

共 30 条

[1]

Parker S.L., Tong T., Bolden S., Wingo P.A., Cancer statistics, CA Cancer J Clin, 46, pp. 5-27, (1996)

[2]

Dijkman G.A., Debruyne F.M., Epidemiology of prostate cancer, Eur Urol, 30, (1996)

[3]

Labrie F., Cusan L., Gomez J.L., Diamond P., Candas B., Combination of screening and preoperative endocrine therapy: The potential for an important decrease in prostate cancer mortality, J Clin Endocr Metab, 80, pp. 2002-2013, (1996)

[4]

De Luka L.M., Darwiche N., Jones C.S., Scita G., Retinoids in differentiation and neoplasia, Scientific American, pp. 28-37, (1995)

[5]

Van Der Leede B.M., Geertzema J., Vroom T.M., Et al., Immunohistochemical analysis of retinoic acid receptor-α in human breast tumors, Am J Pathol, 148, pp. 1905-1914, (1996)

[6]

Katsetos C.D., Stadnicka I., Boyd J.C., Et al., Cellular distribution of retinoic acid receptor-α protein in serous adenocarcinomas of ovarian, tubal and peritoneal origin, Am J Pathol, 153, pp. 469-480, (1998)

[7]

Prayson R.A., Cyclin D1 and MIB1 immunohistochemistry in ependymomas, Am J Clin Pathol, 110, pp. 629-634, (1998)

[8]

Lai R., Medeiros L.J., Wilson C.S., Et al., Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1 and Ki67 in multiple myeloma: Correlation with cyclin D1 immunoreactivity, Mod Pathol, 11, 7, pp. 642-647, (1998)

[9]

Renshaw A.A., Loughlin K.R., Dutta A., Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms, Mod Pathol, 11, 10, pp. 963-966, (1998)

[10]

Gleason D.F., Classification of prostatic carcinomas, Cancer Chemother Rep, 50, pp. 125-136, (1996)

← 1 2 3 →